FRANKLINTON, N.C.--(BUSINESS WIRE)--Novozymes: Novozymes’ sales rose by 15% in local currencies in the first nine months of 2007. Measured in DKK sales rose by 11% to DKK 5,594 million from DKK 5,038 million in 2006. Growth in local currencies excluding acquisitions was 12% Operating profit rose by 14% to DKK 1,149 million for the first nine months of 2007 from DKK 1,006 million in 2006. The operating profit margin including one-off items was 20.5% against 20.0% in 2006 One-off items (settlement relating to patent suit, cf. Stock exchange announcement no. 14/2007) had a positive impact on operating profit of DKK 75 million. Operating profit excluding one-off items rose by 7% in the first nine months of 2007
